• Home
  • Press
  • Contact
  • Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to primary sidebar

TearClear logo

Preservative-free ophthalmic drug delivery

  • Home
  • Press
  • Contact

In the News

  • December, 2020: TearClear Completes Pre-IND FDA Meeting for Preservative Free Multi-Dose Delivery of Latanoprost
  • October, 2020: Glaucoma & ocular surface preservation: Key factors for ODs to consider (Optometry Times)
  • October, 2020: The scourge of preserved eye drops (Ocular Surgery News)
  • June, 2020: Dry Eye Therapies on the Horizon (Opthalmology Management)
  • April 15, 2020: Early-Stage Company Aims to Disrupt Global Ophthalmologic Drugs Market (eyewire News)
  • November 25, 2019: Wet cheekbones: Is it time to move away from eye drops? (Healio Ocular Surgery News)
  • November 12, 2019: We’ve got your BAK (OIS)
Facebook0Tweet0LinkedIn0Email0Print0

Primary Sidebar

Press

  • Press Releases
  • In the News
  • Interviews
  • Downloads

Copyright © 2017–2021 TearClear Corp · All Rights Reserved · Design and development by Sky Dog Technologies

Share this ArticleLike this article? Email it to a friend!

Email sent!